BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27832312)

  • 1. Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue.
    Jost G; Frenzel T; Lohrke J; Lenhard DC; Naganawa S; Pietsch H
    Eur Radiol; 2017 Jul; 27(7):2877-2885. PubMed ID: 27832312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
    Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
    Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal Intensity of the Cerebrospinal Fluid after Intravenous Administration of Gadolinium-based Contrast Agents: Strong Contrast Enhancement around the Vein of Labbe.
    Ohashi T; Naganawa S; Ogawa E; Katagiri T; Kuno K
    Magn Reson Med Sci; 2019 Jul; 18(3):194-199. PubMed ID: 30416181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.
    Ayers-Ringler J; McDonald JS; Connors MA; Fisher CR; Han S; Jakaitis DR; Scherer B; Tutor G; Wininger KM; Dai D; Choi DS; Salisbury JL; Jannetto PJ; Bornhorst JA; Kadirvel R; Kallmes DF; McDonald RJ
    Radiology; 2022 Mar; 302(3):676-683. PubMed ID: 34931861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Gadolinium-based Contrast Agent after Leaking into the Cerebrospinal Fluid: Comparison between the Cerebral Cisterns and the Lateral Ventricles.
    Ohashi T; Naganawa S; Iwata S; Kuno K
    Magn Reson Med Sci; 2021 Jun; 20(2):175-181. PubMed ID: 32641590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
    Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
    Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age Dependence of Gadolinium Leakage from the Cortical Veins into the Cerebrospinal Fluid Assessed with Whole Brain 3D-real Inversion Recovery MR Imaging.
    Naganawa S; Nakane T; Kawai H; Taoka T
    Magn Reson Med Sci; 2019 Apr; 18(2):163-169. PubMed ID: 30393275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
    Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
    Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Glymphatic System on the Kinetic and Distribution of Gadodiamide in the Rat Brain: Observations by Dynamic MRI and Effect of Circadian Rhythm on Tissue Gadolinium Concentrations.
    Taoka T; Jost G; Frenzel T; Naganawa S; Pietsch H
    Invest Radiol; 2018 Sep; 53(9):529-534. PubMed ID: 29652699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study.
    Knobloch G; Frenzel T; Pietsch H; Jost G
    Invest Radiol; 2020 Jun; 55(6):367-373. PubMed ID: 31985602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
    Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
    Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glymphatic Pathway of Gadolinium-Based Contrast Agents Through the Brain: Overlooked and Misinterpreted.
    Deike-Hofmann K; Reuter J; Haase R; Paech D; Gnirs R; Bickelhaupt S; Forsting M; Heußel CP; Schlemmer HP; Radbruch A
    Invest Radiol; 2019 Apr; 54(4):229-237. PubMed ID: 30480554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
    Ozturk K; Nascene D
    AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
    [No Abstract]   [Full Text] [Related]  

  • 18. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
    Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
    Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
    Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
    J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain tissue gadolinium retention in pediatric patients after contrast-enhanced magnetic resonance exams: pathological confirmation.
    Stanescu AL; Shaw DW; Murata N; Murata K; Rutledge JC; Maloney E; Maravilla KR
    Pediatr Radiol; 2020 Mar; 50(3):388-396. PubMed ID: 31989188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.